CD274 and glioblastoma: A recent metanalysis of nine studies, including 806 GBM patients, indicated that PD-L1 expression in tumor tissues was significantly related to a poor clinical outcome (HR = 1.63, 95% CI: 1.19–2.24, p = 0.003) [59].